Aditxt Revenue and Competitors

Loma Linda, CA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Aditxt's estimated annual revenue is currently $4.8M per year.(i)
  • Aditxt's estimated revenue per employee is $155,000

Employee Data

  • Aditxt has 31 Employees.(i)
  • Aditxt grew their employee count by -6% last year.

Aditxt's People

NameTitleEmail/Phone
1
Co-Founder, Chairman and CEOReveal Email/Phone
2
Co-Founder and CIOReveal Email/Phone
3
Chief M&A OfficerReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Chief Operating OfficerReveal Email/Phone
7
SVP, Clinical Development - TransplantationReveal Email/Phone
8
VP, Revenue OperationsReveal Email/Phone
9
VP - FinanceReveal Email/Phone
10
VP BioinformaticsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Aditxt?

Aditx Therapeutics, Inc. (Aditxtâ„¢) is a pre-clinical stage, life sciences company with a mission to prolong life and enhance life quality of transplanted patients. Aditxtâ„¢'s current portfolio includes an exclusive worldwide license for commercializing Apoptotic DNA Immunotherapyâ„¢ (ADiâ„¢), which utilizes a novel approach that mimics the way our bodies naturally induce tolerance to our own tissues.

keywords:N/A

N/A

Total Funding

31

Number of Employees

$4.8M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aditxt News

2022-04-17 - Aditxt, Inc. Partners with Guthy-Renker Affiliate GRS to Launch ...

Aditxt is a biotech innovation company developing technologies focused on mapping and reprogramming the immune system.

2022-04-06 - Aditxt Signs Revenue-Sharing Agreement with Cellvera for up ...

Aditxt is a biotech innovation company developing technologies focused on mapping and reprogramming the immune system. Aditxt's immune mapping...

2022-03-22 - Aditxt to Participate in the 2022 Virtual Growth Conference

Aditxt is a biotech innovation company developing technologies focused on mapping and reprogramming the immune system.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.8M31-6%N/A
#2
$7.8M36-3%N/A
#3
$4M360%N/A
#4
$8.4M39-20%N/A
#5
$18.1M720%N/A